Search - tctmd.com

Displaying 21 - 40 of 132

Sort: Relevancy | Date

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

L.A. McKeown

August 20, 2021

News Daily News

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Yael L. Maxwell

April 29, 2021

News Daily News

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Michael O'Riordan

March 23, 2021

News Daily News

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Michael O'Riordan

February 26, 2021

News Daily News

Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed

Todd Neale

January 28, 2021

News Daily News

FDA Grants Stroke Prevention Indication to Ticagrelor

Shelley Wood

November 06, 2020

News Daily News

Strokes Impacted as COVID-19 Hit the Northeastern US

Caitlin E. Cox

August 10, 2020

News Conference News TVT 2020

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Michael O'Riordan

June 23, 2020

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

News Daily News

Ticagrelor Hits Mark in Large Stroke Study: THALES Top-line Results

Michael O'Riordan

January 27, 2020

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Daily News

Clopidogrel-Aspirin in Minor Stroke/TIA of Maximum Benefit in First 21 Days

Todd Neale

July 09, 2019

News Daily News

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

Yael L. Maxwell

April 01, 2019

News Daily News

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Daily News

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

Shelley Wood

January 22, 2019

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Conference News ESC 2018

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Shelley Wood

August 26, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

Shelley Wood

January 23, 2018

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

Advertisement

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

Short DAPT Bests Aspirin at Preventing Recurrent Events After Stroke, TIA

Eating More Ultraprocessed ‘Junk’ Food Linked to Higher CVD Risk

Antiplatelets, Especially Cilostazol, Helpful in Moyamoya Arteriopathy

Post-TIA Stroke Risk Has Come Down Over Time, but Vigilance Still Needed

FDA Grants Stroke Prevention Indication to Ticagrelor

Strokes Impacted as COVID-19 Hit the Northeastern US

Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Ticagrelor Hits Mark in Large Stroke Study: THALES Top-line Results

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Clopidogrel-Aspirin in Minor Stroke/TIA of Maximum Benefit in First 21 Days

First US Consensus Statement on PFO Closure Addresses Volume Requirements, Quality Measurements

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Late Follow-up of PFO Closure for Stroke Raises Questions for Antiplatelet Duration

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Aspirin Fails to Prevent CV Events in People at ‘Moderate’ Risk of Disease: ARRIVE

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Largest Study to Date Supports Surgical LAA Closure in A-fib Patients

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content